Classification of the incidence of adverse events according to the recommendations of the World Health Organization (WHO):
infrequently from> 1/1000 to <1/100;
rarely from> 1/10000 to <1/1000;
very rarely <1/10000, including individual messages;
the frequency is unknown - it is not possible to establish the frequency of occurrence from the available data.
From the immune system:
very rarely - generalized skin rash, allergic reactions (hives, hypersensitivity: angioedema).
From the respiratory and thoracic and mediastinal organs:
very rarely - attacks of suffocation, bronchospastic reactions.
From the skin:
often erythema, dermatitis, including contact dermatitis (symptoms: eczema, itching, swelling of the treated area of the skin, rash, papules, vesicles, peeling); rarely bullous dermatitis;
very rarely - the reaction of photosensitization, pustular eruptions.